HYFT Stock Analysis: Buy, Sell, or Hold?
HYFT - MindWalk Holdings Corp. Common Stock
$1.80
-0.17 (-8.63%)
▼
5d:
+5.26%
30d:
+45.16%
90d:
+52.54%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Mar 12, 2026
0d
Get Alerted When HYFT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called HYFT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: HYFT is 7.8% above its trading range ($1.67). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: HYFT is 7.8% above its trading range ($1.67). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: HYFT is currently trading at $1.80, which is considered extended relative to its 30-day fair value range of $1.17 to $1.67. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.7) compared to its historical average (85.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HYFT is in a downtrend. Immediate support is located at $1.22, while resistance sits at $1.99. Short-term momentum is weak, with the stock down 8.6% recently.
Market Sentiment: HYFT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+140.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HYFT is in a downtrend. Immediate support is located at $1.22, while resistance sits at $1.99. Short-term momentum is weak, with the stock down 8.6% recently.
Market Sentiment: HYFT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+140.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.17 -
$1.67
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range (+7.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.6%)
- BULLISH: Trading 140.7% below Wall St target ($4.33)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$1.17 -
$1.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$1.99
Current Trend
Downtrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.65
Wall Street Target
$4.33
(+140.7%)
Revenue Growth (YoY)
52.4%
Profit Margin
-43.6%
PE vs Historical
-9.7 vs 85.2
CHEAP
Share & Embed Analysis
Last updated: June 03, 2026 5:23 PM ET
Data refreshes hourly during market hours. Next update: 6:23 PM
Data refreshes hourly during market hours. Next update: 6:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYFT showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$252 | 54 HOLD |